Drug Discovery & Pharmaceuticals

RSS

Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Scientists at The Scripps Research Institute aim to improve flu and malaria vaccines with the support of a new $12 million grant from the Bill & Melinda Gates Foundation.

3 May 2018

Study opens the way for potential new dementia treatments with existing drugs

A new research study by scientists in Australia and the US provides an explanation for why clinical trials of drugs reducing proteins in the brain that were thought to cause dementia and Alzheimer's have failed. The study has opened the way for potential new treatments with existing drugs.

2 May 2018

Scientists discover new target in the treatment of pulmonary hypertension

In a recent study, scientists found that eliminating the FoxM1 gene could improve outcomes for patients with pulmonary hypertension.

1 May 2018

Novel cell-based screening array reduces time and cost of drug discovery

Porvair Sciences has collaborated with Persomics Inc. to develop and supply ANSI/SLAS format Arrays as an OEM product for their ImagineArray™ platform.

From Porvair Sciences Limited 28 Apr 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

Researchers find new cost-effective way to predict interaction of chemical compounds

New research has revealed that simple, commercially available computer programs could be used to design next generation drug-delivery systems by predicting more easily how different chemical compounds interact.

26 Apr 2018

Experimental drug for rheumatoid arthritis prevents side effect of stem cell transplants

An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows.

25 Apr 2018

New compound could offer pain-relieving properties without risk of addiction

Researchers at the University of Michigan have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.

24 Apr 2018

Studies show hemp's potential for treating ovarian cancer

Results from some of the first studies to examine hemp's ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn't have any psychoactive properties or cause addiction.

24 Apr 2018

Researchers develop new vaccine to help people overcome bath salts abuse

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts. The vaccine blunts the illegal stimulant's effects on the brain, which could help recovering drug users who experience a relapse.

23 Apr 2018

Newly developed drug compound may help treat Charcot-Marie-Tooth disease

Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet and legs.

20 Apr 2018

Experimental compound reduces destructive inflammation to improve stroke outcome

An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

20 Apr 2018

Tradeshow Talks with FarmaTrust

The Farmatrust was formed in 2016 with the vision that we will have consumer apps to figure out the authenticity of the drug at a packet level.

19 Apr 2018

Genetic make-up impacts long-term effectiveness of phobia treatment

Researchers have discovered that variations in the efficacy of psychological treatment for phobias are associated with the serotonin transporter gene.

19 Apr 2018

Novel biomarker can distinguish between benign and malignant lung nodules

Researchers report a newly developed biomarker was 98% effective at distinguishing between benign and malignant lung nodules in a recent multicentre clinical trial.

18 Apr 2018

Researchers discover potential hurdle for personalized medicine

A recent study has shown that loss of the Erk oncogene can stimulate tumorigenesis in cells where Ras has been eliminated. The findings may have important consequences for the development of personalized medicines that target Ras.

17 Apr 2018

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal.

16 Apr 2018

Researchers use graphene to disrupt biofilms on dental implants

Researchers from Chalmers University of Technology, Sweden have demonstrated that a layer of graphene can form a protective film on the surface of implants that could prevent bacterial infection.

16 Apr 2018

Researchers use graphene to disrupt biofilms on dental implants

Researchers from Chalmers University of Technology, Sweden have demonstrated that a layer of graphene can form a protective film on the surface of implants that could prevent bacterial infection.

16 Apr 2018

SYGNIS AG extends manufacturing capability for Lightning-Link technology

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.

16 Apr 2018